OncoResponse collaborates with strategic development partners to create therapeutically important antibody products. We are actively seeking partners to help us discover, develop and commercialize therapeutics in oncology. Strategic partnerships can be structured on the basis of disease area(s), collaboration roles, degree of financial risk-sharing, and commercial territory.
- Robust and proven fully human mAb discovery platform
- Demonstrated development capabilities
- Strong research & development pipeline in multiple oncology indications
To date, we have formed multiple strategic collaborations to evaluate the adaptive immune response in Elite Responders to immunotherapy using our validated platform technology.